Author/Authors :
Nozue، نويسنده , , Tsuyoshi and Yamamoto، نويسنده , , Shingo and Tohyama، نويسنده , , Shinichi and Fukui، نويسنده , , Kazuki and Umezawa، نويسنده , , Shigeo and Onishi، نويسنده , , Yuko and Kunishima، نويسنده , , Tomoyuki and Sato، نويسنده , , Akira and Nozato، نويسنده , , Toshihiro and Miyake، نويسنده , , Shogo and Takeyama، نويسنده , , Youichi and Morino، نويسنده , , Yoshihiro and Yamauchi، نويسنده , , Tak، نويسنده ,
Abstract :
Although statin-induced regression in coronary atherosclerosis seems to be greater in patients with acute coronary syndrome than in those with stable coronary artery disease, no reports have examined this. The purpose of the present study was to compare the changes in coronary atherosclerosis in patients with stable versus unstable angina pectoris (AP). The effects of 8-month statin therapy on coronary atherosclerosis were evaluated using virtual histology intravascular ultrasound, and analyzable intravascular ultrasound data were obtained from 119 patients (83 patients with stable AP and 36 with unstable AP). A significant decrease in plaque volume was observed in patients with unstable AP (−2.2%, p = 0.02) but not in patients with stable AP. A significant increase in the necrotic-core component (0.30 mm3/mm, p = 0.009) was observed only in patients with unstable AP. Significant positive correlations were observed between the percentage of change in platelet-activating factor acetylhydrolase and the percentage of change in plaque volume (r = 0.346, p = 0.05) in patients with unstable AP. No significant correlations were observed in patients with stable AP. Multivariate regression analyses showed that a reduction in platelet-activating factor acetylhydrolase was associated with regression in coronary atherosclerosis, particularly of the fibrous component (β = 0.443, p = 0.003), in patients with unstable AP. In conclusion, regression of the coronary artery plaque volume was greater, although statin therapy did not halt the increases in plaque vulnerability, in patients with unstable AP compared to those with stable AP. A reduction in the serum platelet-activating factor acetylhydrolase level was associated with regression in coronary atherosclerosis, particularly the fibrous plaque volume, in patients with unstable AP.
